Gilhus, Nils Erik http://orcid.org/0000-0001-6522-5102
Funding for this research was provided by:
University of Bergen
Article History
Received: 8 March 2023
Revised: 14 April 2023
Accepted: 16 April 2023
First Online: 26 April 2023
Declarations
:
: N.E. Gilhus has received financial support from UCB, Argenx, Janssen, Alexion, Merck, Roche, and Immunovant.